Published in Arch Dermatol on August 01, 2000
Cutaneous lupus erythematosus: diagnosis and treatment. Best Pract Res Clin Rheumatol (2013) 0.97
Cutaneous lupus and the Cutaneous Lupus Erythematosus Disease Area and Severity Index instrument. Rheum Dis Clin North Am (2010) 0.89
Topical tacrolimus and pimecrolimus in the treatment of cutaneous lupus erythematosus: an evidence-based evaluation. Eur J Clin Pharmacol (2007) 0.86
Lupus erythematosus tumidus: a unique disease entity. Hawaii J Med Public Health (2014) 0.80
Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus: a review of literature. Pediatr Rheumatol Online J (2015) 0.77
Lupus erythematosus revisited. Semin Immunopathol (2015) 0.76
[Skin manifestations in lupus erythematosus: clinical aspects and therapy]. Z Rheumatol (2011) 0.76
Questions answered and a $1 million question raised concerning lupus erythematosus tumidus: is routine laboratory surveillance testing during treatment with hydroxychloroquine for skin disease really necessary. Arch Dermatol (2000) 0.75
Tumid lupus erythematosus: an intriguing dermatopathological connotation treated successfully with topical tacrolimus and hydroxyxhloroquine combination. Indian J Dermatol (2014) 0.75
Lupus erythematosus tumidus: A case and discussion of a rare entity in black patients. JAAD Case Rep (2016) 0.75
Asymptomatic erythematous plaque. Indian Dermatol Online J (2016) 0.75
Cutaneous lupus erythematosus: updates on pathogenesis and associations with systemic lupus. Curr Opin Rheumatol (2016) 0.75
Coexistence of tumid lupus erythematosus with systemic lupus erythematosus and discoid lupus erythematosus: a report of two cases of tumid lupus. J Clin Rheumatol (2008) 0.75
Lupus tumidus: a report of two cases. An Bras Dermatol (2017) 0.75
The Cutaneous Spectrum of Lupus Erythematosus. Clin Rev Allergy Immunol (2017) 0.75
Long-term (6 and 12 months) follow-up of two prospective, randomized, controlled phase III trials of photodynamic therapy with BF-200 ALA and methyl aminolaevulinate for the treatment of actinic keratosis. Br J Dermatol (2013) 2.70
Noninvasive in vivo detection and quantification of Demodex mites by confocal laser scanning microscopy. Br J Dermatol (2012) 2.67
Up-regulation of macrophage inflammatory protein-3 alpha/CCL20 and CC chemokine receptor 6 in psoriasis. J Immunol (2000) 2.66
Missense mutations in SMOH in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res (1998) 2.41
The Maudsley Addiction Profile (MAP): a brief instrument for assessing treatment outcome. Addiction (1998) 2.41
Extent of misclassification of death from Creutzfeldt-Jakob disease in England 1979-96: retrospective examination of clinical records. BMJ (2000) 2.32
Reagent for the enzymatic determination of serum total triglycerides with improved lipolytic efficiency. J Clin Chem Clin Biochem (1984) 2.25
A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis. Immunol Today (1998) 2.19
[Medical information and patients' choices. Influences on term singleton breech deliveries]. Gynecol Obstet Fertil (2007) 2.03
High-dose UVA1 radiation therapy for localized scleroderma. J Am Acad Dermatol (1997) 1.96
Cutting edge: the orphan chemokine receptor G protein-coupled receptor-2 (GPR-2, CCR10) binds the skin-associated chemokine CCL27 (CTACK/ALP/ILC). J Immunol (2000) 1.95
Methadone treatment practices and outcome for opiate addicts treated in drug clinics and in general practice: results from the National Treatment Outcome Research Study. Br J Gen Pract (1999) 1.95
Somatic mutations in the PTCH, SMOH, SUFUH and TP53 genes in sporadic basal cell carcinomas. Br J Dermatol (2005) 1.90
Porokeratosis: present concepts. J Eur Acad Dermatol Venereol (2011) 1.90
Usefulness of specific immunotherapy in patients with atopic dermatitis and allergic sensitization to house dust mites: a multi-centre, randomized, dose-response study. Allergy (2006) 1.80
Photodynamic therapy with BF-200 ALA for the treatment of actinic keratosis: results of a multicentre, randomized, observer-blind phase III study in comparison with a registered methyl-5-aminolaevulinate cream and placebo. Br J Dermatol (2011) 1.75
Mutations in the human homologue of the Drosophila segment polarity gene patched (PTCH) in sporadic basal cell carcinomas of the skin and primitive neuroectodermal tumors of the central nervous system. Cancer Res (1997) 1.73
Superimposed lateralized exanthem of childhood: report of a case related to adenovirus infection. Clin Exp Dermatol (2014) 1.73
Epidermal keratinocyte expression of inducible nitric oxide synthase in skin lesions of psoriasis vulgaris. Lancet (1994) 1.64
Systematic mutation screening of KRT5 supports the hypothesis that Galli-Galli disease is a variant of Dowling-Degos disease. Br J Dermatol (2010) 1.63
Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema. Br J Dermatol (2009) 1.60
Ultraviolet A1 (340-400 nm) phototherapy for cutaneous T-cell lymphoma. J Am Acad Dermatol (1999) 1.59
Novel Hairless mutations in two kindreds with autosomal recessive papular atrichia. J Invest Dermatol (1999) 1.58
Acquired syphilis II in early childhood: reappearance of syphilis brephotrophica. J Am Acad Dermatol (1998) 1.49
Supravenous hyperpigmentation in association with CHOP chemotherapy of a CD30 (Ki-1)-positive anaplastic large-cell lymphoma. Dermatology (1995) 1.46
[Sudden greying or whitening of the scalp hair]. Dtsch Med Wochenschr (1995) 1.45
A genotype-phenotype correlation in HNPCC: strong predominance of msh2 mutations in 41 patients with Muir-Torre syndrome. J Med Genet (2004) 1.45
Dithranol: a review of the mechanism of action in the treatment of psoriasis vulgaris. Skin Pharmacol (1990) 1.43
Red lunulae in severe alopecia areata. Acta Derm Venereol (1992) 1.42
Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet (1998) 1.41
Efficacy and skin tolerability of Saliker in the treatment of dandruff. Eur J Dermatol (2002) 1.40
Papular-purpuric 'gloves and socks' syndrome associated with human herpesvirus 6 infection. Arch Dermatol (1998) 1.40
The hand eczema proteome: imbalance of epidermal barrier proteins. Br J Dermatol (2015) 1.40
Persistent granulomatous plaque type zoster in a patient with HIV infection. Int J Dermatol (2011) 1.38
[The differential diagnosis of nodular tumors of the hand]. Dtsch Med Wochenschr (1994) 1.38
Assessing the effectiveness of Dead Sea products. Isr Med Assoc J (2007) 1.37
Schnitzler's syndrome: diagnosis, treatment, and follow-up. Allergy (2013) 1.35
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) (2008) 1.32
Critical role of neutrophils for the generation of psoriasiform skin lesions in flaky skin mice. J Invest Dermatol (2000) 1.32
Singlet oxygen mediates the UVA-induced generation of the photoaging-associated mitochondrial common deletion. J Biol Chem (1999) 1.31
Enzyme plus light therapy to repair DNA damage in ultraviolet-B-irradiated human skin. Proc Natl Acad Sci U S A (2000) 1.28
Targeted treatment of pyoderma gangrenosum in PAPA (pyogenic arthritis, pyoderma gangrenosum and acne) syndrome with the recombinant human interleukin-1 receptor antagonist anakinra. Br J Dermatol (2009) 1.26
Construction and validation of a photographic guide for assessing severity of chronic hand dermatitis. Br J Dermatol (2005) 1.24
Economic burden of drug dependency. Social costs incurred by drug users at intake to the National Treatment Outcome Research Study. Br J Psychiatry (1998) 1.24
Role of integrin alphaE(CD103)beta7 for tissue-specific epidermal localization of CD8+ T lymphocytes. J Invest Dermatol (2001) 1.20
Congenital erythropoietic porphyria. J Am Acad Dermatol (1997) 1.17
Imiquimod 5% cream for the treatment of superficial and nodular basal cell carcinoma: randomized studies comparing low-frequency dosing with and without occlusion. Br J Dermatol (2002) 1.15
Interferon beta induces interleukin-10 expression: relevance to multiple sclerosis. Ann Neurol (1996) 1.15
Arylhydrocarbon hydroxylase activity in lymphocytes of patients with psoriasis. Lancet (1980) 1.14
Nitric oxide in human skin: current status and future prospects. J Invest Dermatol (1998) 1.13
Cellular aspects of callosal connections and their development. Neuropsychologia (1995) 1.12
Surface roughness measurement by means of polychromatic speckle elongation. Appl Opt (1997) 1.11
Morphologic investigations on the rebound phenomenon after corticosteroid-induced atrophy in human skin. J Invest Dermatol (1984) 1.09
[Significance of the neuraminidase inhibitor oseltamivir for the management of seasonal influenza]. Dtsch Med Wochenschr (2008) 1.08
Morphology of basal cell carcinoma in high definition optical coherence tomography: en-face and slice imaging mode, and comparison with histology. J Eur Acad Dermatol Venereol (2012) 1.08
Mechanism of action of human pancreatic and salivary alpha-amylase on alpha-4-nitrophenyl maltoheptaoside substrate. Clin Chem (1982) 1.07
Type 1 segmental cutaneous leiomyomatosis. Clin Exp Dermatol (2002) 1.07
Interleukin-8 receptor-mediated chemotaxis of normal human epidermal cells. FEBS Lett (1992) 1.05
Actinic keratosis in the en-face and slice imaging mode of high-definition optical coherence tomography and comparison with histology. Br J Dermatol (2012) 1.05
Skin levels of arachidonic acid-derived inflammatory mediators and histamine in atopic dermatitis and psoriasis. J Invest Dermatol (1986) 1.04
Is the mismatch repair deficient type of Muir-Torre syndrome confined to mutations in the hMSH2 gene? Hum Genet (1996) 1.04
Treatment of refractory pityriasis rubra pilaris with oral alitretinoin: case report. Br J Dermatol (2010) 1.04
Calcipotriol cream with or without concurrent topical corticosteroid in psoriasis: tolerability and efficacy. Br J Dermatol (1998) 1.04
A proinflammatory activity of interleukin 8 in human skin: expression of the inducible nitric oxide synthase in psoriatic lesions and cultured keratinocytes. J Exp Med (1996) 1.04
Changes in arachidonic acid metabolism in UV-irradiated hairless mouse skin. J Invest Dermatol (1983) 1.02
Evidence that singlet oxygen-induced human T helper cell apoptosis is the basic mechanism of ultraviolet-A radiation phototherapy. J Exp Med (1997) 1.02
Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro. J Immunol (1993) 1.02
Low number of regulatory T cells in skin lesions of patients with cutaneous lupus erythematosus. Arthritis Rheum (2007) 1.01
Phase-contrast MR imaging support for the diagnosis of aqueductal stenosis. AJNR Am J Neuroradiol (2008) 1.00
Corticosteroid atrophy in human skin. A study by light, scanning, and transmission electron microscopy. J Invest Dermatol (1983) 1.00
Dapsone in the treatment of lupus erythematosus. Br J Dermatol (1981) 0.99
Biphasic effect of exogenous nitric oxide on proliferation and differentiation in skin derived keratinocytes but not fibroblasts. J Invest Dermatol (1998) 0.99
Preferential relative porphyrin enrichment in solar keratoses upon topical application of delta-aminolevulinic acid methylester. Photochem Photobiol (1998) 0.99
Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment. Allergy (2008) 0.99
[Bithalamic infarct: is there an evocative aspect? Radioclinical study]. Rev Neurol (Paris) (2008) 0.99
Human eosinophils produce biologically active IL-12: implications for control of T cell responses. J Immunol (1998) 0.99
Gianotti-Crosti syndrome associated with Epstein-Barr virus infection. Pediatr Dermatol (1997) 0.98
Schönlein-Henoch purpura associated with gastric Helicobacter pylori infection. J Am Acad Dermatol (1995) 0.97
A route to hierarchical materials based on complexes of metallosupramolecular polyelectrolytes and amphiphiles. Proc Natl Acad Sci U S A (2000) 0.97
Mortality from dementias and neurodegenerative disorders in people aged 15-64 in England and Wales in 1979-96. BMJ (1998) 0.97
[Atypical fibroxanthoma of the scalp: overview and recent developments]. Hautarzt (2014) 0.97
MSH6 mutation in Muir-Torre syndrome: could this be a rare finding? Br J Dermatol (2007) 0.96
An innovative water-soluble biopolymer improves efficacy of ciclopirox nail lacquer in the management of onychomycosis. J Eur Acad Dermatol Venereol (2009) 0.96
Defects of mitochondrial respiratory chain in multiple symmetric lipomatosis. Arch Dermatol Res (1998) 0.96
Allelic losses on chromosome arm 10q and mutation of the PTEN (MMAC1) tumour suppressor gene in primary and metastatic malignant melanomas. Virchows Arch (2000) 0.96
Psoralen photoactivation promotes morphological and functional changes in fibroblasts in vitro reminiscent of cellular senescence. J Cell Sci (1998) 0.94
Pyoderma gangrenosum after cesarean delivery. Am J Obstet Gynecol (2000) 0.94